Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Intrathecal Hydrocortisone/Intrathecal Methotrexate/Pegaspargase/Thioguanine/Vincristine Regimen

Preferred Label : Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Intrathecal Hydrocortisone/Intrathecal Methotrexate/Pegaspargase/Thioguanine/Vincristine Regimen;

NCIt synonyms : Cyclophosphamide/Cytarabine/Daunorubicin/Dexmethasone/Pegaspargase/Thioguanine/Vincristine/Intrathecal Hydrocortisone/Intrathecal Methotrexate; Cyclophosphamide-Cytarabine-Daunorubicin-Dexamethasone-Intrathecal Hydrocortisone-Intrathecal Methotrexate-Pegaspargase-Thioguanine-Vincristine; Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Intrathecal Hydrocortisone/Intrathecal Methotrexate/Pegaspargase/Thioguanine/Vincristine; Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Hydrocortisone Intrathecal/Methotrexate Intrathecal/Pegaspargase/Thioguanine/Vincristine; Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Intrathecal Hydrocortisone/Intrathecal Methotrexate/Oral Methotrexate/Pegaspargase/Thioguanine/Vincristine Regimen;

NCIt definition : A regimen consisting of cyclophosphamide, cytarabine, daunorubicin, dexamethasone, intrathecal hydrocortisone, intrathecal methotrexate, pegaspargase, thioguanine, and vincristine that can be used in the treatment of acute lymphoblastic leukemia (ALL).;

Details

Origin ID

C210487;

chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Cytarabine Hydrochloride [NCIt concept]
- Daunorubicin Hydrochloride [NCIt concept]
- Dexamethasone [NCIt concept]
- Methotrexate [NCIt concept]
- Pegaspargase [NCIt concept]
- Therapeutic Hydrocortisone [NCIt concept]
- Thioguanine [NCIt concept]
- Vincristine Sulfate [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients